J
Josemir W. Sander
Researcher at UCL Institute of Neurology
Publications - 705
Citations - 44517
Josemir W. Sander is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Epilepsy & Population. The author has an hindex of 106, co-authored 680 publications receiving 39038 citations. Previous affiliations of Josemir W. Sander include University of Cincinnati & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Assessing suicidal risk with antiepileptic drugs.
TL;DR: The issue of suicidality in epilepsy is likely to represent an example of how the underdiagnosis of psychiatric symptoms, the lack of input from professionals, and the delay in an optimized AED therapy may worsen the prognosis of the condition with the occurrence of severe complications such as suicide.
Book Chapter
The incidence and prevalence of epilepsy
Josemir W. Sander,Simon Shorvon +1 more
TL;DR: The authors found that 20−30% of those attending tertiary referral centres with refractory epilepsy do not in fact have epilepsy, with the most common differential diagnoses being dissociative seizures and syncope.
Journal ArticleDOI
Traditional practices and perceptions of epilepsy among people in Roma communities in Bulgaria
TL;DR: The majority of Roma children with epilepsy are likely to leave school early, are greatly limited in their choice of spouse (particularly girls), and marriages often occur between people with epilepsy or those with a family history of epilepsy.
Journal ArticleDOI
Phase clustering in transcranial magnetic stimulation-evoked EEG responses in genetic generalized epilepsy and migraine.
Prisca R. Bauer,Robert M. Helling,Matthijs J.L. Perenboom,Fernando H. Lopes da Silva,Else A. Tolner,Michel D. Ferrari,Josemir W. Sander,Gerhard H. Visser,Stiliyan Kalitzin +8 more
TL;DR: The results suggest that the higher propensity to phase clustering is not shared between genetic generalized epilepsy and migraine, and methods to quantifyphase clustering using TMS-EEG are presented and show its potential value as a measure of brain network activity in Genetic generalized epilepsy.
Journal ArticleDOI
Medication burden in epilepsy: Exploring the impact of non-epilepsy concomitant drugs load
TL;DR: Chronic non-epilepsy chronic medication use was more prevalent in people with epilepsy across all therapeutic drug classes and most comorbidities measured using the Rx Risk score.